Congressional leaders continue to negotiate with the White House on what many suspect could be the final COVID-19 relief bill, and the House, Senate and Trump Administration remain far apart on their preferred approaches. While the House passed a relief bill—the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act—in May, the Senate has only recently introduced its counterpart proposal, the Healthcare, Economic Assistance, Liability, And Schools (HEALS) Act. Though the Senate is scheduled to begin its August recess on Friday August 7, policymakers are reportedly pessimistic about reaching a deal before then. Senate leaders are expected to delay the start of the recess in hopes of reaching a deal the following week. While members of the House have already returned home, Representatives could be called back with 24 hours’ notice to vote on a final package.
The Senate’s coronavirus stimulus package, the HEALS Act, includes supplemental appropriations for federal science agencies, notably $15.5 billion for the National Institutes of Health and $3.4 billion for the CDC. The House’s HEREOS Act proposed additional funding for NIH ($4.75 billion), CDC ($2.1 billion), and the National Science Foundation ($125 million), among other agencies. Neither bill includes the Research Investments to Spark the Economy (RISE) Act, a bipartisan bill that seeks $26 billion in relief funding to federal science agencies to support non-COVID university-based research that has been impacted by the pandemic.
The Senate HEALS Act does not include language sought by Census stakeholders, and requested by the Administration, to extend the 2020 Census statutorily required deadlines (see related article). The Census Project, of which COSSA is a member, has worked with various partners to craft a sign-on letter urging the Senate to include language that would extend the deadlines by four months. Interested organizations (not individuals) can sign the letter by August 5.
Finally, the Senate COVID package incorporates the Safeguarding American Innovation Act, a bill seeking to address research security concerns, but itself raising concerns within the scientific community about the approach taken (see related article).
Leadership in the House and Senate will continue to work on a COVID-19 compromise over the coming weeks. COVID relief aside, when Congress returns after Labor Day, lawmakers will have fewer than 20 working days to take action on fiscal year (FY) 2021 appropriations bills before the end of the fiscal year on September 30, after which lawmakers will head home again in advance of the November elections.
Back to this issue’s table of contents.